IRIS - Res&Arch Institutional Research Information System - Research & Archive

FAGOTTI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.235
NA - Nord America 2.189
AS - Asia 472
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 1
Totale 4.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.188
IE - Irlanda 608
SE - Svezia 383
UA - Ucraina 341
IT - Italia 280
FI - Finlandia 185
SG - Singapore 179
DE - Germania 172
RU - Federazione Russa 138
VN - Vietnam 113
HK - Hong Kong 100
CN - Cina 36
FR - Francia 31
GB - Regno Unito 29
CH - Svizzera 26
TR - Turchia 16
UZ - Uzbekistan 11
AT - Austria 10
CZ - Repubblica Ceca 9
NL - Olanda 9
LB - Libano 7
PL - Polonia 7
EU - Europa 6
GR - Grecia 5
KR - Corea 5
AE - Emirati Arabi Uniti 2
PK - Pakistan 2
BG - Bulgaria 1
CA - Canada 1
IN - India 1
NG - Nigeria 1
NO - Norvegia 1
Totale 4.903
Salva come PNG Salva come JPEG
Città #
Dublin 608
Chandler 463
San Mateo 328
Altamura 174
Medford 167
Princeton 164
Lawrence 121
Wilmington 116
Andover 113
Dong Ket 113
Singapore 103
Hong Kong 100
Boardman 60
Saint Petersburg 50
Falls Church 34
Beijing 32
Norwalk 27
Ann Arbor 26
Cattolica 19
Helsinki 18
San Paolo di Civitate 17
Izmir 16
Des Moines 15
Perugia 15
Hanover 11
Den Haag 9
Caivano 7
Moscow 7
Ashburn 6
Los Angeles 6
Rome 6
Seoul 5
Tappahannock 5
Chicago 4
Fremont 4
Jacksonville 4
Milan 4
Shanghai 4
Frankfurt Am Main 3
Lappeenranta 3
Prague 3
Dubai 2
Karachi 2
New York 2
Auburn Hills 1
Edmonton 1
Florence 1
Genova 1
Kiev 1
Lagos 1
Lausanne 1
Leawood 1
Ludwigshafen 1
Naples 1
Nichelino 1
Paderno Dugnano 1
Pannarano 1
Portici 1
Redmond 1
Salerno 1
Trento 1
Trevi 1
Vicenza 1
Totale 3.015
Salva come PNG Salva come JPEG
Nome #
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. 67
Advanced ovarian cancer: diagnosis and prediction of optimal cytoreduction 63
Laparoendoscopic single-site surgery for fertility-sparing staging of border line ovarian tumors: initial experience. 61
Isterectomia laparoscopica: chirurgica single-port e mini-laparoscopia 60
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. 59
Reply to "Let’s Think Twice Before Abandoning Fibrillar Oxidized Regenerated Cellulose" 57
Chirurgia nella terapia primaria del carcinoma ovarico 55
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up. 55
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. 53
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 52
Postoperative ileus after para-aortic lymphadenectomy: a prospective study. 52
Surgical management of advanced ovarian cancer: a 20-years experience in a tertiary gynecologic oncology unit. 51
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. 50
Antiestrogeni e apoptosi 50
Laparoscopy and ovarian cancer: from diagnosis to recurrence 50
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. 49
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue. 47
Isterectomia laparoscopica semplice e radicale: terminologia, classificazione e tecnica chirurgica. In: Isterectomia laparoscopica. 47
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 47
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. 46
Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients. 46
O538 A RANDOMIZED STUDY COMPARING THE USE OF THE LIGACLIP WITH ENSEAL TO PREVENT LYMPHOCELE DURING LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR GYNECOLOGIC CANCER 46
Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer. 45
Total laparo-endoscopic single site surgery (less) hysterectomy in low-risk early endometrial cancer: technique and preliminary results 44
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis. 44
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer. 44
A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. 44
Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation 43
Reply to: Laparoscopy or minilaparotomy as minimally invasive surgical approach for uterine leiomyomas? An unsolved question 42
Advances in surgical management of cervical cancer. 41
M487 PLATELET GEL AND VULVAR CARCINOMA: A PILOT STUDY 41
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. 40
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. 40
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). 40
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery. 40
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. 39
Carcinosi peritoneali 39
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. 39
Simple conization and lymphadenectomy for the conservative treatment of stage ib1 cervical cancer 38
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results. 36
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 36
Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: A double-institution case–control study 36
Laparoscopic diagnosis of asymptomatic megaureter. 35
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer. 35
Recurrence: diagnosis and indications for secondary surgery 35
La recidiva: diagnosi e indicazioni alla chirurgia secondaria 35
Nuovi fattori prognostici in ginecologia oncologica 35
Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications. 35
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions]. 35
Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient. 35
A prospective study of laparoscopy versus minilaparotomy in the treatment of uterine myomas. 35
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. 34
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. 34
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. 34
Isterectomia laparoscopica 34
The lymphatic drainage of the uterine cervix in adult fresh cadavers: anatomy and surgical implications. 34
Laparoscopic myomectomy at 25 weeks of pregnancy: case report. 34
Laparoscopic colorectal resection for bowel endometriosis: feasibility, complications, and clinical outcome. 34
Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: A multi-institutional study 34
Endometrial cancer arising in both horns of didelphys uterus in a Down's syndrome woman. 33
A multi-centric trial to validate the reliability of a laparoscopic score to assess intraperitoneal diffusion of the advanced ovarian cancer 33
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 33
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. 33
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 33
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome. 32
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 32
Diagnosi e trattamento dei tumori del collo dell'utero 32
Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. 32
Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome. 31
Tumori maligni del collo dell’utero 31
Morbidity and outcomes after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 205 patients 31
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer. 31
Laparoendoscopic single-site surgery for total hysterectomy. 31
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. 31
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. 31
Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications 31
Laparoscopia e cancro ovarico: dalla diagnosi alla recidiva 30
Which role for pre-treatment laparoscopic staging? 30
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 30
Peritoneal carcinosis of ovarian origin. 30
Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. 30
Survival after pelvic exenteration for cervical cancer: a retrospective multicentric study of 158 patients 30
A multicentric trial (Olympia–MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer 30
Laparoendoscopic single-site surgery (less) in early endometrial cancer: a multi-institutional evaluation 29
Laparoendoscopic single-site surgery for the treatment of benign adnexal disease: a prospective trial. 29
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study. 28
Laparoendoscopic single-site surgery for the treatment of benign adnexal diseases: a pilot study. 28
Pre-hysterectomy conization is able to predict response in locally advanced cervical cancer patients undergone to neoadjuvant chemoradiation 28
Minilaparoscopic Versus Single-Port Total Hysterectomy: A Randomized Trial 28
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment. 27
Oestrogen and progesterone receptors in ovarian carcinoma. 27
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. 27
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study. 27
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology. 27
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 26
Pelvic disease in primary advanced ovarian cancer: the role of peritonectomy of douglas compared with rectosigmoid resection 26
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience 26
O724. A PROSPECTIVE MULTI-CENTRIC TRIAL (PROTOCOL ID: OLYMPIA – MITO 13) TO VALIDATE THE RELIABILITY OF A LAPAROSCOPIC SCORE IN AOC PATIENTS TO ASSESS INTRAPERITONEAL DIFFUSION OF THE DISEASE 26
Urologic surgery in gynecologic oncology: A large single-institution experience 26
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. 26
Totale 3.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 5 9 2 0 4 1 4 3 144 28 3 2
2020/2021940 0 101 44 104 331 85 9 0 66 42 24 134
2021/20221.115 21 193 9 52 18 20 13 474 11 6 14 284
2022/20231.929 166 314 0 132 202 179 4 91 775 2 44 20
2023/2024494 56 91 34 7 3 2 107 3 1 14 60 116
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 5.075